JP2025510781A5 - - Google Patents
Info
- Publication number
- JP2025510781A5 JP2025510781A5 JP2024556421A JP2024556421A JP2025510781A5 JP 2025510781 A5 JP2025510781 A5 JP 2025510781A5 JP 2024556421 A JP2024556421 A JP 2024556421A JP 2024556421 A JP2024556421 A JP 2024556421A JP 2025510781 A5 JP2025510781 A5 JP 2025510781A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant gene
- polypeptide
- amino acid
- effector
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323248P | 2022-03-24 | 2022-03-24 | |
| US63/323,248 | 2022-03-24 | ||
| US202263381255P | 2022-10-27 | 2022-10-27 | |
| US63/381,255 | 2022-10-27 | ||
| US202363489873P | 2023-03-13 | 2023-03-13 | |
| US63/489,873 | 2023-03-13 | ||
| PCT/US2023/064887 WO2023183893A1 (en) | 2022-03-24 | 2023-03-23 | Engineered gene effectors, compositions, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510781A JP2025510781A (ja) | 2025-04-15 |
| JP2025510781A5 true JP2025510781A5 (cg-RX-API-DMAC7.html) | 2026-03-25 |
Family
ID=88102034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556421A Pending JP2025510781A (ja) | 2022-03-24 | 2023-03-23 | 組換え遺伝子エフェクターならびにその組成物および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250388634A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4499838A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025510781A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119256086A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023241162A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3253453A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023183893A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025507822A (ja) | 2022-03-01 | 2025-03-21 | エピクリスパー バイオテクノロジーズ, インコーポレイテッド | 組換えヌクレアーゼならびにその組成物および使用方法 |
| CN116769916B (zh) * | 2023-06-27 | 2025-03-07 | 南通大学附属医院 | Tmed8基因在制备胰腺癌药物及其诊断试剂盒中的应用 |
| EP4774383A1 (en) | 2023-09-06 | 2026-07-15 | Epicrispr Biotechnologies, Inc. | Engineered cas12 polypeptides, compositions, and methods of use thereof |
| WO2026090457A1 (en) * | 2024-10-25 | 2026-04-30 | Stark Therapeutics Corporation | Methods of treatment of metabolic diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024526895A (ja) * | 2021-07-20 | 2024-07-19 | エピクリスパー バイオテクノロジーズ, インコーポレイテッド | 標的遺伝子を調節するための系および方法 |
-
2023
- 2023-03-23 JP JP2024556421A patent/JP2025510781A/ja active Pending
- 2023-03-23 EP EP23775904.8A patent/EP4499838A4/en active Pending
- 2023-03-23 WO PCT/US2023/064887 patent/WO2023183893A1/en not_active Ceased
- 2023-03-23 CN CN202380042287.1A patent/CN119256086A/zh active Pending
- 2023-03-23 AU AU2023241162A patent/AU2023241162A1/en active Pending
- 2023-03-23 US US18/842,718 patent/US20250388634A1/en active Pending
- 2023-03-23 CA CA3253453A patent/CA3253453A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Emili et al. | Species-specific interaction of the glutamine-rich activation domains of Spl with the TATA box-binding protein | |
| JP2025063029A5 (cg-RX-API-DMAC7.html) | ||
| JP2022522650A5 (cg-RX-API-DMAC7.html) | ||
| Matuoka et al. | A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs | |
| JP2023512824A5 (cg-RX-API-DMAC7.html) | ||
| JP2025114573A5 (cg-RX-API-DMAC7.html) | ||
| JP2017018125A5 (cg-RX-API-DMAC7.html) | ||
| CA2386471C (en) | Purification of recombinant proteins fused to multiple epitopes | |
| JP2001506851A (ja) | 原核生物の二ハイブリッド系 | |
| US7045677B2 (en) | Fusion proteins incorporating lysozyme | |
| JPWO2021117848A5 (cg-RX-API-DMAC7.html) | ||
| Ehrenman et al. | Characterization of cDNAs encoding the murine A+ U-rich RNA-binding protein AUF1 | |
| JP2022545625A5 (cg-RX-API-DMAC7.html) | ||
| JP2003511014A5 (cg-RX-API-DMAC7.html) | ||
| EP1131448A2 (en) | Producing antimicrobial cationic peptides as fusion proteins | |
| US20050260715A1 (en) | Efficient methods for producing antimicrobial cationic peptides in host cells | |
| JPWO2023038128A5 (cg-RX-API-DMAC7.html) | ||
| JP2009291139A (ja) | 真核細胞において組換えタンパク質を細胞外に放出させるためのポリヌクレオチド | |
| JP2024513231A5 (cg-RX-API-DMAC7.html) | ||
| CN100584945C (zh) | 调节基因表达的核被膜和核纤层结合嵌合体 | |
| JPWO2023120658A5 (cg-RX-API-DMAC7.html) | ||
| JP2023532415A5 (cg-RX-API-DMAC7.html) | ||
| US11208444B2 (en) | BRCA2-mediated purification of recombinase protein | |
| US20050100894A1 (en) | Novel mitogen activated kinase | |
| WO2026088062A1 (en) | Artificial transcription factors |